Show simple item record

AuthorFarooqui, Habib Hasan
AuthorKaran, Anup
AuthorMehta, Aashna
AuthorBabu, Giridhara Rathnaiah
Authorvan Schayck, Onno C.P.
Available date2025-09-22T06:21:12Z
Publication Date2025-12-01
Publication NameBMC Infectious Diseases
Identifierhttp://dx.doi.org/10.1186/s12879-025-11082-3
CitationFarooqui, H.H., Karan, A., Mehta, A. et al. Did the periodic intensification of routine immunisation strategy (Intensified mission Indradhanush) reduce the demand for pediatric antibiotic formulations in India?. BMC Infect Dis 25, 741 (2025). https://doi.org/10.1186/s12879-025-11082-3
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105005726969&origin=inward
URIhttp://hdl.handle.net/10576/67415
AbstractBackground: Recent research has indicated an increase in antibiotic utilisation, particularly pediatric formulations. Furthermore, an increasing trend in antimicrobial resistance rates has also been reported. Empirical evidence suggests that immunisation reduces the demand for antibiotics. We examined the potential impact of the periodic intensification of the routine immunisation strategy - Intensified Mission Indradhanush (IMI), which was implemented from October 2017 to January 2018, on antibiotic utilisation in India. Methods: We analysed the PharmaTrac dataset to assess the impact of IMI on antibiotic utilisation. We conducted interrupted time series analyses by fitting a Poisson regression model. We used Newey–West standard errors to account for autocorrelation and heteroskedasticity. Findings: Poisson segmented regression analysis showed a 12.6% decrease in Fluoroquinolones sales in the first month of IMI implementation (incidence rate ratio [IRR] 0.874, 95%CI: 0.777–0.983). However, post-intervention, their sales remained broadly constant (IRR 1.000, 95%CI 0.995–1.006). Similarly, Chloramphenicol sales decreased by 0.6% in the first month, whereas sales increased by a trend of 0.4% per month (IRR 1.004, 95%CI 0.991–1.017) post-intervention. Interestingly, Trimethoprim sales increased by 17.1% in the first month but decreased by 0.4% per month (IRR 0.959, 95%CI 0.945–0.973) post-intervention. However, there was a modest increase in sales of Macrolides by 3.0%, Cephalosporins by 2.9% and broad-spectrum Penicillin by 0.2% in the first month. Thereafter, Macrolides sales increased by a monthly rate of 0.5% (IRR 1.005, 95% CI 1.000–1.010), Cephalosporins increased by 0.5% (IRR 1.005, 95% CI 1.000 -1.010) and Broad spectrum penicillin increased by 0.9% (IRR 1.009, 95% CI 1.004–1.013) in the post-intervention period. Furthermore, there were heterogeneities across Indian states. Interpretation: The IMI’s impact on antibiotic utilisation was heterogeneous across antibiotic classes and Indian states.
SponsorOpen Access funding is provided by the Qatar National Library.
Languageen
PublisherSpringer Nature
SubjectAntibiotic utilisation
Immunisation
India
Intensified mission Indradhanush
Interrupted time series
TitleDid the periodic intensification of routine immunisation strategy (Intensified mission Indradhanush) reduce the demand for pediatric antibiotic formulations in India?
TypeArticle
Issue Number1
Volume Number25
ESSN1471-2334
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record